Published in Cancer on September 15, 1993
Hemophagocytic syndromes and infection. Emerg Infect Dis (2001) 4.94
Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest (1997) 1.41
An animal model for human EBV-associated hemophagocytic syndrome: herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits. Am J Pathol (2001) 0.82
Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge. Allergy Asthma Clin Immunol (2005) 0.79
Nasal angiocentric lymphoma with hemophagocytic syndrome. Korean J Intern Med (1999) 0.75
Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 10.45
Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1999) 7.93
Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med (1998) 7.12
Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry (1974) 6.97
Keratin expression in human tissues and neoplasms. Histopathology (2002) 4.91
Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol (1991) 4.48
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol (2000) 4.46
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol (1997) 3.83
Changes in axon fluorescence during activity: molecular probes of membrane potential. J Membr Biol (1974) 3.80
Changes in absorption, fluorescence, dichroism, and Birefringence in stained giant axons: : optical measurement of membrane potential. J Membr Biol (1977) 3.49
Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol (1992) 3.33
Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med (1995) 3.31
Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
A strain-driven morphotropic phase boundary in BiFeO3. Science (2009) 2.95
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol (2001) 2.82
Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal (1997) 2.77
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol (1984) 2.53
Identification and Estimation of Catabolic Pathways of Glucose in Fruits. Plant Physiol (1958) 2.39
Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol (1991) 2.37
Improvements in optical methods for measuring rapid changes in membrane potential. J Membr Biol (1981) 2.34
Chagas' disease. Clin Microbiol Rev (1992) 2.30
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med (1993) 2.27
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol (1994) 2.23
Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. Hum Pathol (1995) 2.22
SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma. Blood (1989) 2.17
Conversion of sterigmatocystin to aflatoxin B 1 by Aspergillus parasiticus. Biochem Biophys Res Commun (1973) 2.13
Automated fluorescence polarization immunoassay for monitoring vancomycin. Ther Drug Monit (1983) 2.11
Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol (1987) 2.10
Splenic vascular tumors: a histologic, immunophenotypic, and virologic study. Am J Surg Pathol (1997) 2.09
New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol (1992) 2.02
IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol (1999) 2.00
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med (1988) 1.99
Unruptured left ventricular pseudoaneurysm following myocardial infarction. Heart (1998) 1.92
The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol (1995) 1.92
Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol (2001) 1.91
Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol (1991) 1.89
Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum Mol Genet (1999) 1.86
Detection of Epstein-Barr Virus in inflammatory pseudotumor. Semin Diagn Pathol (1998) 1.86
Mechanism of potential-dependent light absorption changes of lipid bilayer membranes in the presence of cyanine and oxonol dyes. J Membr Biol (1977) 1.85
Differential SMN2 expression associated with SMA severity. Nat Genet (1998) 1.84
Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood (1993) 1.82
Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke (1997) 1.81
Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol (1992) 1.75
Small subunit rRNA sequence of Enterocytozoon bieneusi and its potential diagnostic role with use of the polymerase chain reaction. J Infect Dis (1993) 1.73
Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol (1993) 1.71
Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res (1997) 1.69
Trends in severity of hospitalized myocardial infarction: the atherosclerosis risk in communities (ARIC) study, 1987-1994. Am Heart J (2000) 1.69
Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med (1985) 1.68
Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun (2001) 1.66
Conversion of averufin into aflatoxins by Aspergillus parasiticus. Biochemistry (1973) 1.64
Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas. Int J Oncol (1998) 1.62
Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors. Am J Surg Pathol (1997) 1.62
Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol (1992) 1.60
Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol (1992) 1.58
Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature. Am J Surg Pathol (1998) 1.56
Large field-induced strains in a lead-free piezoelectric material. Nat Nanotechnol (2011) 1.53
The biogenesis of ethylene in penicillium digitatum. Plant Physiol (1968) 1.53
Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med (1986) 1.53
Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A (2005) 1.52
CTL effector function within the central nervous system requires CD4+ T cells. J Immunol (1998) 1.52
Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol (1998) 1.50
Coronary heart disease trends in four United States communities. The Atherosclerosis Risk in Communities (ARIC) study 1987-1996. Int J Epidemiol (2001) 1.49
Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol (1999) 1.49
Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma. Clin Chem (1981) 1.48
A method for testing the nonrandomness of chromosomal breakpoints. Cytogenet Cell Genet (1993) 1.48
Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Gastroenterology (2000) 1.48
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women. Fertil Steril (1998) 1.46
Glutamine-enriched enteral diet enhances bacterial clearance in protected bacterial peritonitis, regardless of glutamine form. JPEN J Parenter Enteral Nutr (1997) 1.46
Nucleotide sequence of the genomic RNA of bamboo mosaic potexvirus. J Gen Virol (1994) 1.44
Immunoglobulin gene rearrangements in Hodgkin's disease. Hum Pathol (1986) 1.43
Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas. Am J Pathol (1985) 1.43
Scanning electron microscopy of operatively excised severely regurgitant floppy mitral valves. Am J Cardiol (1989) 1.42
Hepatitis B virus X protein inhibits transforming growth factor-beta -induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem (2000) 1.40
Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization. Arch Pathol Lab Med (1997) 1.40
Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats. JPEN J Parenter Enteral Nutr (1997) 1.40
Hepatitis E virus and primary biliary cirrhosis. QJM (1997) 1.40
The effect of decalcification on in situ hybridization. Mod Pathol (1997) 1.39
Glutamine-enhanced bacterial killing by neutrophils from postoperative patients. Nutrition (1997) 1.39
Distribution of progesterone and its metabolites in cattle tissues following administration of progesterone-4-14C1,2,3,4. J Anim Sci (1977) 1.39
Effects of parenteral infusion with fish-oil or safflower-oil emulsion on hepatic lipids, plasma amino acids, and inflammatory mediators in septic rats. Nutrition (2000) 1.39
Alanylglutamine-enriched total parenteral nutrition improves protein metabolism more than branched chain amino acid-enriched total parenteral nutrition in protracted peritonitis. J Trauma (1997) 1.39
Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes. Infect Immun (1998) 1.37
Expressed cadherin pseudogenes are localized to the critical region of the spinal muscular atrophy gene. Proc Natl Acad Sci U S A (1995) 1.37
Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: a report from the Taiwan Pediatric Oncology Group (TPOG) Acta Paediatr Taiwan (2000) 1.37
Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene. Proc Natl Acad Sci U S A (1995) 1.36
Constancy of growth on simple and complex media. J Bacteriol (1978) 1.34
Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis (2000) 1.34
c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol (1994) 1.34
Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia--the occurrence of retinoic acid syndrome is a risk factor. Leukemia (1999) 1.33
Prevalence of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon (Septata) intestinalis among patients with AIDS-related diarrhea: determination by polymerase chain reaction to the microsporidian small-subunit rRNA gene. Clin Infect Dis (1996) 1.33
Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol (1986) 1.32
Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood (1991) 1.32
Expression of Tie-2, angiopoietin-1, angiopoietin-2, ephrinB2 and EphB4 in pyogenic granuloma of human gingiva implicates their roles in inflammatory angiogenesis. J Periodontal Res (2000) 1.32
Initial characterization of CST1, a Toxoplasma gondii cyst wall glycoprotein. Infect Immun (2001) 1.31
Averufin in the biosynthesis of aflatoxin B. J Am Chem Soc (1973) 1.30
Biosynthesis of aflatoxin. Conversion of norsolorinic acid and other hypothetical intermediates into aflatoxin B1. J Agric Food Chem (1977) 1.30